{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:20Z","timestamp":1772166320325,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Takeda Korea"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Gaucher disease (GD) is an autosomal recessive condition caused by insufficient glucocerebrosidase activity. The Gaucher Earlier Diagnosis Consensus (GED-C) initiative created a point-scoring system (PSS) to facilitate the early identification of GD based on significant indicators and covariables. This study aimed to evaluate the applicability and utility of the GED-C PSS in pediatric and young adult patients in Korea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included both retrospective analysis and prospective recruitment. Subject recruitment involved 14 sites across 13 hospitals in Korea, where patients of any age meeting GED-C criteria were recruited, and blood samples were collected. Data of 513 subjects were analyzed and two patients were confirmed to have GD during prospective enrollment. The median age of participants was 10\u00a0years (range: 1\u00a0month to 40\u00a0years). Receiver operating characteristic analysis revealed a cutoff point of 6.5 for GED-C PSS (area under the curve of 0.9883) demonstrated high sensitivity (1.0) and specificity (0.97). A histogram indicated that the PSS scores of the two confirmed GD patients were distinct from those of other participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study suggests that GED-C PSS shows potential for the early diagnosis of GD, supporting its broader clinical use for both children and adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03891-1","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:17:19Z","timestamp":1762777039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Gaucher Earlier Diagnosis Consensus point-scoring system for children and young adults: a retrospective and prospective evaluation in Korea"],"prefix":"10.1186","volume":"20","author":[{"given":"Seung Min","family":"Hahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minseok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youna","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nack-Gyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye Jee","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hawk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Joon","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoung Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Rok","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Mo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7124-7818","authenticated-orcid":false,"given":"Chuhl Joo","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"2","key":"3891_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/ijms18020441","volume":"18","author":"J Stirnemann","year":"2017","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, et al. A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci. 2017;18(2):441.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3891_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2022.03.001","volume":"136","author":"NJ Weinreb","year":"2022","unstructured":"Weinreb NJ, Goker-Alpan O, Kishnani PS, Longo N, Burrow TA, Bernat JA, et al. The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? Mol Genet Metab. 2022;136(1):4\u201321.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"3891_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","volume":"76","author":"E Orvisky","year":"2002","unstructured":"Orvisky E, Park JK, LaMarca ME, Ginns EI, Martin BM, Tayebi N, et al. Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. Mol Genet Metab. 2002;76(4):262\u201370.","journal-title":"Mol Genet Metab"},{"issue":"12","key":"3891_CR4","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1515\/cclm-2020-0306","volume":"58","author":"E Lepe-Balsalobre","year":"2020","unstructured":"Lepe-Balsalobre E, Santotoribio JD, Nu\u00f1ez-Vazquez R, Garc\u00eda-Morillo S, Jim\u00e9nez-Arriscado P, Hern\u00e1ndez-Ar\u00e9valo P, et al. Genotype\/phenotype relationship in Gaucher disease patients Novel mutation in glucocerebrosidase gene. Clin Chem Lab Med. 2020;58(12):2017\u201324.","journal-title":"Clin Chem Lab Med"},{"issue":"S1","key":"3891_CR5","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1002\/ajh.24063","volume":"90","author":"GA Grabowski","year":"2015","unstructured":"Grabowski GA, Zimran A, Ida H. Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher registry. Am J Hematol. 2015;90(S1):S12\u20138.","journal-title":"Am J Hematol"},{"key":"3891_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","volume":"190","author":"BK Burton","year":"2017","unstructured":"Burton BK, Charrow J, Hoganson GE, Waggoner D, Tinkle B, Braddock SR, et al. Newborn screening for lysosomal storage disorders in illinois: the initial 15-month experience. J Pediatr. 2017;190:130\u20135.","journal-title":"J Pediatr"},{"issue":"8","key":"3891_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/jhg.2017.36","volume":"62","author":"L Kang","year":"2017","unstructured":"Kang L, Zhan X, Gu X, Zhang H. Successful newborn screening for Gaucher disease using fluorometric assay in China. J Hum Genet. 2017;62(8):763\u20138.","journal-title":"J Hum Genet"},{"issue":"2","key":"3891_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10545-017-0098-3","volume":"41","author":"AB Burlina","year":"2018","unstructured":"Burlina AB, Polo G, Salviati L, Duro G, Zizzo C, Dardis A, et al. Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy. J Inherit Metab Dis. 2018;41(2):209\u201319.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"3891_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13023-020-1322-z","volume":"15","author":"YH Chien","year":"2020","unstructured":"Chien YH, Lee NC, Chen PW, Yeh HY, Gelb MH, Chiu PC, et al. Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns. Orphanet J Rare Dis. 2020;15(1):38.","journal-title":"Orphanet J Rare Dis"},{"key":"3891_CR10","first-page":"100850","volume":"31","author":"T Sawada","year":"2022","unstructured":"Sawada T, Kido J, Sugawara K, Yoshida S, Matsumoto S, Shimazu T, et al. Newborn screening for Gaucher disease in Japan. Mol Genet Metab Rep. 2022;31:100850.","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"3891_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ymgme.2021.12.009","volume":"135","author":"PS Kishnani","year":"2022","unstructured":"Kishnani PS, Al-Hertani W, Balwani M, G\u00f6ker-Alpan \u00d6, Lau HA, Wasserstein M, et al. Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: results from a Delphi consensus. Mol Genet Metab. 2022;135(2):154\u201362.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"3891_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/imj.14156","volume":"49","author":"A Mehta","year":"2019","unstructured":"Mehta A, Kuter DJ, Salek SS, Belmatoug N, Bembi B, Bright J, et al. Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative. Intern Med J. 2019;49(5):578\u201391.","journal-title":"Intern Med J"},{"issue":"12","key":"3891_CR13","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1111\/imj.14942","volume":"50","author":"A Mehta","year":"2020","unstructured":"Mehta A, Rivero-Arias O, Abdelwahab M, Campbell S, McMillan A, Rolfe MJ, et al. Scoring system to facilitate diagnosis of Gaucher disease. Intern Med J. 2020;50(12):1538\u201346.","journal-title":"Intern Med J"},{"key":"3891_CR14","first-page":"100725","volume":"27","author":"MJ Savolainen","year":"2021","unstructured":"Savolainen MJ, Karlsson A, Rohkimainen S, Toppila I, Lassenius MI, Falconi CV, et al. The Gaucher Earlier Diagnosis Consensus point-scoring system (GED-C PSS): Evaluation of a prototype in Finnish Gaucher disease patients and feasibility of screening retrospective electronic health record data for the recognition of potential undiagnosed patients in Finland. Mol Genet Metabol Rep. 2021;27:100725.","journal-title":"Mol Genet Metabol Rep"},{"issue":"1","key":"3891_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13023-024-03042-y","volume":"19","author":"S Revel-Vilk","year":"2024","unstructured":"Revel-Vilk S, Shalev V, Gill A, Paltiel O, Manor O, Tenenbaum A, et al. Assessing the diagnostic utility of the Gaucher Earlier Diagnosis Consensus (GED-C) scoring system using real-world data. Orphanet J Rare Dis. 2024;19(1):71.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3891_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32-5.","journal-title":"Cancer"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03891-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03891-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03891-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:03:44Z","timestamp":1762819424000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03891-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3891"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03891-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6280810\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures in this study were performed in accordance with the ethical standards of the Institutional Review Board of Severance Hospital and principles set out in the Declaration of Helsinki. The study received the Institutional Review Board approval (Severance Hospital IRB 4-2019-0279), and informed consent was obtained from adult patients and the parents of pediatric participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consent form we used included a statement confirming consent for publication. However, the manuscript does not contain any identifiable information about an individual.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"C.J.L received funding from Takeda to conduct the study. All other authors declare no competing interests related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"569"}}